FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma.

Philipp LohmannPantelis StavrinouKatharina LipkeElena K BauerGarry CecconJan-Michael WernerBernd NeumaierGereon R FinkNadim J ShahKarl-Josef LangenNorbert Galldiks

Published in: European journal of nuclear medicine and molecular imaging (2018)

Our results show that the metabolically active tumour volume delineated by FET PET is significantly larger than tumour volume delineated by CE. Furthermore, the results strongly suggest that the information derived from both imaging modalities should be integrated into the management of patients with newly diagnosed glioblastoma.

Keyphrases

newly diagnosed
computed tomography
pet ct
positron emission tomography
magnetic resonance imaging
high resolution
pet imaging
contrast enhanced
risk factors
health information
magnetic resonance